nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramipril—BCHE—diaphragm—liver cancer	0.0565	0.501	CbGeAlD
Ramipril—ACE—umbilical vein—liver cancer	0.0343	0.304	CbGeAlD
Ramipril—ACE—embryo—liver cancer	0.00895	0.0794	CbGeAlD
Ramipril—Mitiglinide—PPARG—liver cancer	0.00608	0.371	CrCbGaD
Ramipril—Benazepril—MTHFR—liver cancer	0.00605	0.369	CrCbGaD
Ramipril—SLC15A1—liver—liver cancer	0.00577	0.0512	CbGeAlD
Ramipril—ACE—liver—liver cancer	0.00414	0.0367	CbGeAlD
Ramipril—Nateglinide—PPARG—liver cancer	0.0031	0.189	CrCbGaD
Ramipril—BCHE—liver—liver cancer	0.00306	0.0271	CbGeAlD
Ramipril—Neuropathy—Doxorubicin—liver cancer	0.00253	0.0029	CcSEcCtD
Ramipril—Dyspnoea—Sorafenib—liver cancer	0.00251	0.00288	CcSEcCtD
Ramipril—Dyspepsia—Sorafenib—liver cancer	0.00247	0.00284	CcSEcCtD
Ramipril—Rash maculo-papular—Doxorubicin—liver cancer	0.00245	0.00281	CcSEcCtD
Ramipril—Decreased appetite—Sorafenib—liver cancer	0.00244	0.00281	CcSEcCtD
Ramipril—Gastrointestinal disorder—Sorafenib—liver cancer	0.00243	0.00279	CcSEcCtD
Ramipril—Fatigue—Sorafenib—liver cancer	0.00242	0.00278	CcSEcCtD
Ramipril—Photosensitivity—Epirubicin—liver cancer	0.00241	0.00276	CcSEcCtD
Ramipril—Constipation—Sorafenib—liver cancer	0.0024	0.00276	CcSEcCtD
Ramipril—Vascular purpura—Epirubicin—liver cancer	0.00236	0.00271	CcSEcCtD
Ramipril—Hepatic failure—Epirubicin—liver cancer	0.00235	0.0027	CcSEcCtD
Ramipril—Gastrointestinal pain—Sorafenib—liver cancer	0.0023	0.00264	CcSEcCtD
Ramipril—Renal failure acute—Epirubicin—liver cancer	0.00229	0.00263	CcSEcCtD
Ramipril—Dermatitis exfoliative—Epirubicin—liver cancer	0.00224	0.00257	CcSEcCtD
Ramipril—Urticaria—Sorafenib—liver cancer	0.00223	0.00256	CcSEcCtD
Ramipril—Photosensitivity—Doxorubicin—liver cancer	0.00223	0.00256	CcSEcCtD
Ramipril—Abdominal pain—Sorafenib—liver cancer	0.00222	0.00255	CcSEcCtD
Ramipril—Body temperature increased—Sorafenib—liver cancer	0.00222	0.00255	CcSEcCtD
Ramipril—Renal impairment—Epirubicin—liver cancer	0.00222	0.00255	CcSEcCtD
Ramipril—Purpura—Epirubicin—liver cancer	0.00219	0.00252	CcSEcCtD
Ramipril—Vascular purpura—Doxorubicin—liver cancer	0.00219	0.00251	CcSEcCtD
Ramipril—Anaphylactoid reaction—Epirubicin—liver cancer	0.00218	0.00251	CcSEcCtD
Ramipril—Hepatic failure—Doxorubicin—liver cancer	0.00218	0.0025	CcSEcCtD
Ramipril—Hypoglycaemia—Epirubicin—liver cancer	0.00217	0.00249	CcSEcCtD
Ramipril—Cardiac failure—Epirubicin—liver cancer	0.00217	0.00249	CcSEcCtD
Ramipril—Cerebrovascular accident—Epirubicin—liver cancer	0.00216	0.00248	CcSEcCtD
Ramipril—Hyponatraemia—Epirubicin—liver cancer	0.00212	0.00244	CcSEcCtD
Ramipril—Renal failure acute—Doxorubicin—liver cancer	0.00212	0.00243	CcSEcCtD
Ramipril—Dermatitis exfoliative—Doxorubicin—liver cancer	0.00207	0.00238	CcSEcCtD
Ramipril—Hypersensitivity—Sorafenib—liver cancer	0.00207	0.00238	CcSEcCtD
Ramipril—Renal impairment—Doxorubicin—liver cancer	0.00205	0.00236	CcSEcCtD
Ramipril—Purpura—Doxorubicin—liver cancer	0.00203	0.00233	CcSEcCtD
Ramipril—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00202	0.00232	CcSEcCtD
Ramipril—Asthenia—Sorafenib—liver cancer	0.00202	0.00232	CcSEcCtD
Ramipril—Cardiac failure—Doxorubicin—liver cancer	0.002	0.0023	CcSEcCtD
Ramipril—Hypoglycaemia—Doxorubicin—liver cancer	0.002	0.0023	CcSEcCtD
Ramipril—Cerebrovascular accident—Doxorubicin—liver cancer	0.002	0.00229	CcSEcCtD
Ramipril—Pruritus—Sorafenib—liver cancer	0.00199	0.00228	CcSEcCtD
Ramipril—Blood creatinine increased—Epirubicin—liver cancer	0.00198	0.00227	CcSEcCtD
Ramipril—Hyponatraemia—Doxorubicin—liver cancer	0.00196	0.00225	CcSEcCtD
Ramipril—Liver function test abnormal—Epirubicin—liver cancer	0.00195	0.00224	CcSEcCtD
Ramipril—Orthostatic hypotension—Epirubicin—liver cancer	0.00193	0.00222	CcSEcCtD
Ramipril—Abdominal pain upper—Epirubicin—liver cancer	0.00193	0.00222	CcSEcCtD
Ramipril—Diarrhoea—Sorafenib—liver cancer	0.00192	0.00221	CcSEcCtD
Ramipril—Breast disorder—Epirubicin—liver cancer	0.00191	0.00219	CcSEcCtD
Ramipril—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.0019	0.00219	CcSEcCtD
Ramipril—Gastritis—Epirubicin—liver cancer	0.00187	0.00215	CcSEcCtD
Ramipril—Dizziness—Sorafenib—liver cancer	0.00186	0.00213	CcSEcCtD
Ramipril—Blood creatinine increased—Doxorubicin—liver cancer	0.00183	0.0021	CcSEcCtD
Ramipril—Dysphagia—Epirubicin—liver cancer	0.00183	0.0021	CcSEcCtD
Ramipril—Influenza—Epirubicin—liver cancer	0.00183	0.0021	CcSEcCtD
Ramipril—Asthma—Epirubicin—liver cancer	0.00183	0.0021	CcSEcCtD
Ramipril—Eosinophilia—Epirubicin—liver cancer	0.00181	0.00208	CcSEcCtD
Ramipril—Liver function test abnormal—Doxorubicin—liver cancer	0.00181	0.00207	CcSEcCtD
Ramipril—Pancreatitis—Epirubicin—liver cancer	0.00179	0.00206	CcSEcCtD
Ramipril—Vomiting—Sorafenib—liver cancer	0.00179	0.00205	CcSEcCtD
Ramipril—Orthostatic hypotension—Doxorubicin—liver cancer	0.00179	0.00205	CcSEcCtD
Ramipril—Abdominal pain upper—Doxorubicin—liver cancer	0.00179	0.00205	CcSEcCtD
Ramipril—Angina pectoris—Epirubicin—liver cancer	0.00178	0.00204	CcSEcCtD
Ramipril—Rash—Sorafenib—liver cancer	0.00177	0.00203	CcSEcCtD
Ramipril—Dermatitis—Sorafenib—liver cancer	0.00177	0.00203	CcSEcCtD
Ramipril—Breast disorder—Doxorubicin—liver cancer	0.00177	0.00203	CcSEcCtD
Ramipril—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00176	0.00202	CcSEcCtD
Ramipril—Headache—Sorafenib—liver cancer	0.00176	0.00202	CcSEcCtD
Ramipril—Bronchitis—Epirubicin—liver cancer	0.00176	0.00202	CcSEcCtD
Ramipril—Pancytopenia—Epirubicin—liver cancer	0.00173	0.00199	CcSEcCtD
Ramipril—Gastritis—Doxorubicin—liver cancer	0.00173	0.00199	CcSEcCtD
Ramipril—Neutropenia—Epirubicin—liver cancer	0.00171	0.00196	CcSEcCtD
Ramipril—Upper respiratory tract infection—Epirubicin—liver cancer	0.0017	0.00195	CcSEcCtD
Ramipril—Dysphagia—Doxorubicin—liver cancer	0.00169	0.00194	CcSEcCtD
Ramipril—Asthma—Doxorubicin—liver cancer	0.00169	0.00194	CcSEcCtD
Ramipril—Influenza—Doxorubicin—liver cancer	0.00169	0.00194	CcSEcCtD
Ramipril—Eosinophilia—Doxorubicin—liver cancer	0.00167	0.00192	CcSEcCtD
Ramipril—Nausea—Sorafenib—liver cancer	0.00167	0.00192	CcSEcCtD
Ramipril—Photosensitivity reaction—Epirubicin—liver cancer	0.00167	0.00191	CcSEcCtD
Ramipril—Weight increased—Epirubicin—liver cancer	0.00166	0.00191	CcSEcCtD
Ramipril—Pancreatitis—Doxorubicin—liver cancer	0.00166	0.0019	CcSEcCtD
Ramipril—Angina pectoris—Doxorubicin—liver cancer	0.00165	0.00189	CcSEcCtD
Ramipril—Bronchitis—Doxorubicin—liver cancer	0.00163	0.00187	CcSEcCtD
Ramipril—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00161	0.00185	CcSEcCtD
Ramipril—Pancytopenia—Doxorubicin—liver cancer	0.0016	0.00184	CcSEcCtD
Ramipril—Renal failure—Epirubicin—liver cancer	0.0016	0.00184	CcSEcCtD
Ramipril—Neuropathy peripheral—Epirubicin—liver cancer	0.0016	0.00183	CcSEcCtD
Ramipril—Stomatitis—Epirubicin—liver cancer	0.00159	0.00182	CcSEcCtD
Ramipril—Jaundice—Epirubicin—liver cancer	0.00159	0.00182	CcSEcCtD
Ramipril—Conjunctivitis—Epirubicin—liver cancer	0.00158	0.00182	CcSEcCtD
Ramipril—Urinary tract infection—Epirubicin—liver cancer	0.00158	0.00182	CcSEcCtD
Ramipril—Neutropenia—Doxorubicin—liver cancer	0.00158	0.00181	CcSEcCtD
Ramipril—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00157	0.0018	CcSEcCtD
Ramipril—Sweating—Epirubicin—liver cancer	0.00156	0.00179	CcSEcCtD
Ramipril—Photosensitivity reaction—Doxorubicin—liver cancer	0.00154	0.00177	CcSEcCtD
Ramipril—Hepatobiliary disease—Epirubicin—liver cancer	0.00154	0.00177	CcSEcCtD
Ramipril—Weight increased—Doxorubicin—liver cancer	0.00154	0.00177	CcSEcCtD
Ramipril—Epistaxis—Epirubicin—liver cancer	0.00154	0.00176	CcSEcCtD
Ramipril—Sinusitis—Epirubicin—liver cancer	0.00153	0.00175	CcSEcCtD
Ramipril—Agranulocytosis—Epirubicin—liver cancer	0.00152	0.00175	CcSEcCtD
Ramipril—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00149	0.00172	CcSEcCtD
Ramipril—Renal failure—Doxorubicin—liver cancer	0.00148	0.0017	CcSEcCtD
Ramipril—Neuropathy peripheral—Doxorubicin—liver cancer	0.00148	0.0017	CcSEcCtD
Ramipril—Stomatitis—Doxorubicin—liver cancer	0.00147	0.00169	CcSEcCtD
Ramipril—Jaundice—Doxorubicin—liver cancer	0.00147	0.00169	CcSEcCtD
Ramipril—Urinary tract infection—Doxorubicin—liver cancer	0.00146	0.00168	CcSEcCtD
Ramipril—Conjunctivitis—Doxorubicin—liver cancer	0.00146	0.00168	CcSEcCtD
Ramipril—Hepatitis—Epirubicin—liver cancer	0.00146	0.00168	CcSEcCtD
Ramipril—Sweating—Doxorubicin—liver cancer	0.00144	0.00166	CcSEcCtD
Ramipril—Oedema peripheral—Epirubicin—liver cancer	0.00144	0.00165	CcSEcCtD
Ramipril—Connective tissue disorder—Epirubicin—liver cancer	0.00144	0.00165	CcSEcCtD
Ramipril—Hepatobiliary disease—Doxorubicin—liver cancer	0.00143	0.00164	CcSEcCtD
Ramipril—Epistaxis—Doxorubicin—liver cancer	0.00142	0.00163	CcSEcCtD
Ramipril—Sinusitis—Doxorubicin—liver cancer	0.00141	0.00162	CcSEcCtD
Ramipril—Visual impairment—Epirubicin—liver cancer	0.00141	0.00162	CcSEcCtD
Ramipril—Agranulocytosis—Doxorubicin—liver cancer	0.00141	0.00161	CcSEcCtD
Ramipril—Erythema multiforme—Epirubicin—liver cancer	0.00138	0.00159	CcSEcCtD
Ramipril—Tinnitus—Epirubicin—liver cancer	0.00136	0.00157	CcSEcCtD
Ramipril—Flushing—Epirubicin—liver cancer	0.00136	0.00156	CcSEcCtD
Ramipril—Hepatitis—Doxorubicin—liver cancer	0.00135	0.00155	CcSEcCtD
Ramipril—Oedema peripheral—Doxorubicin—liver cancer	0.00133	0.00153	CcSEcCtD
Ramipril—Connective tissue disorder—Doxorubicin—liver cancer	0.00133	0.00153	CcSEcCtD
Ramipril—Immune system disorder—Epirubicin—liver cancer	0.00132	0.00152	CcSEcCtD
Ramipril—Mediastinal disorder—Epirubicin—liver cancer	0.00132	0.00151	CcSEcCtD
Ramipril—Arrhythmia—Epirubicin—liver cancer	0.00131	0.0015	CcSEcCtD
Ramipril—Visual impairment—Doxorubicin—liver cancer	0.0013	0.0015	CcSEcCtD
Ramipril—Alopecia—Epirubicin—liver cancer	0.00129	0.00148	CcSEcCtD
Ramipril—Mental disorder—Epirubicin—liver cancer	0.00128	0.00147	CcSEcCtD
Ramipril—Erythema multiforme—Doxorubicin—liver cancer	0.00128	0.00147	CcSEcCtD
Ramipril—Malnutrition—Epirubicin—liver cancer	0.00127	0.00146	CcSEcCtD
Ramipril—Erythema—Epirubicin—liver cancer	0.00127	0.00146	CcSEcCtD
Ramipril—Tinnitus—Doxorubicin—liver cancer	0.00126	0.00145	CcSEcCtD
Ramipril—Flushing—Doxorubicin—liver cancer	0.00126	0.00144	CcSEcCtD
Ramipril—Tension—Epirubicin—liver cancer	0.00125	0.00143	CcSEcCtD
Ramipril—Dysgeusia—Epirubicin—liver cancer	0.00125	0.00143	CcSEcCtD
Ramipril—Nervousness—Epirubicin—liver cancer	0.00124	0.00142	CcSEcCtD
Ramipril—Muscle spasms—Epirubicin—liver cancer	0.00122	0.00141	CcSEcCtD
Ramipril—Immune system disorder—Doxorubicin—liver cancer	0.00122	0.0014	CcSEcCtD
Ramipril—Mediastinal disorder—Doxorubicin—liver cancer	0.00122	0.0014	CcSEcCtD
Ramipril—Arrhythmia—Doxorubicin—liver cancer	0.00121	0.00139	CcSEcCtD
Ramipril—Alopecia—Doxorubicin—liver cancer	0.0012	0.00137	CcSEcCtD
Ramipril—Mental disorder—Doxorubicin—liver cancer	0.00119	0.00136	CcSEcCtD
Ramipril—Ill-defined disorder—Epirubicin—liver cancer	0.00118	0.00136	CcSEcCtD
Ramipril—Malnutrition—Doxorubicin—liver cancer	0.00118	0.00135	CcSEcCtD
Ramipril—Erythema—Doxorubicin—liver cancer	0.00118	0.00135	CcSEcCtD
Ramipril—Agitation—Epirubicin—liver cancer	0.00117	0.00134	CcSEcCtD
Ramipril—Nateglinide—ALB—liver cancer	0.00116	0.0711	CrCbGaD
Ramipril—Tension—Doxorubicin—liver cancer	0.00116	0.00133	CcSEcCtD
Ramipril—Dysgeusia—Doxorubicin—liver cancer	0.00115	0.00132	CcSEcCtD
Ramipril—Malaise—Epirubicin—liver cancer	0.00115	0.00132	CcSEcCtD
Ramipril—Nervousness—Doxorubicin—liver cancer	0.00114	0.00131	CcSEcCtD
Ramipril—Vertigo—Epirubicin—liver cancer	0.00114	0.00131	CcSEcCtD
Ramipril—Syncope—Epirubicin—liver cancer	0.00114	0.00131	CcSEcCtD
Ramipril—Leukopenia—Epirubicin—liver cancer	0.00114	0.00131	CcSEcCtD
Ramipril—Muscle spasms—Doxorubicin—liver cancer	0.00113	0.0013	CcSEcCtD
Ramipril—Palpitations—Epirubicin—liver cancer	0.00112	0.00129	CcSEcCtD
Ramipril—Loss of consciousness—Epirubicin—liver cancer	0.00112	0.00128	CcSEcCtD
Ramipril—Cough—Epirubicin—liver cancer	0.00111	0.00128	CcSEcCtD
Ramipril—Convulsion—Epirubicin—liver cancer	0.0011	0.00127	CcSEcCtD
Ramipril—Ill-defined disorder—Doxorubicin—liver cancer	0.00109	0.00125	CcSEcCtD
Ramipril—Chest pain—Epirubicin—liver cancer	0.00108	0.00124	CcSEcCtD
Ramipril—Myalgia—Epirubicin—liver cancer	0.00108	0.00124	CcSEcCtD
Ramipril—Arthralgia—Epirubicin—liver cancer	0.00108	0.00124	CcSEcCtD
Ramipril—Agitation—Doxorubicin—liver cancer	0.00108	0.00124	CcSEcCtD
Ramipril—Anxiety—Epirubicin—liver cancer	0.00108	0.00124	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00108	0.00124	CcSEcCtD
Ramipril—Discomfort—Epirubicin—liver cancer	0.00107	0.00123	CcSEcCtD
Ramipril—Malaise—Doxorubicin—liver cancer	0.00106	0.00122	CcSEcCtD
Ramipril—Dry mouth—Epirubicin—liver cancer	0.00106	0.00122	CcSEcCtD
Ramipril—Vertigo—Doxorubicin—liver cancer	0.00106	0.00121	CcSEcCtD
Ramipril—Syncope—Doxorubicin—liver cancer	0.00106	0.00121	CcSEcCtD
Ramipril—Leukopenia—Doxorubicin—liver cancer	0.00105	0.00121	CcSEcCtD
Ramipril—Confusional state—Epirubicin—liver cancer	0.00105	0.0012	CcSEcCtD
Ramipril—Palpitations—Doxorubicin—liver cancer	0.00104	0.00119	CcSEcCtD
Ramipril—Anaphylactic shock—Epirubicin—liver cancer	0.00104	0.00119	CcSEcCtD
Ramipril—Oedema—Epirubicin—liver cancer	0.00104	0.00119	CcSEcCtD
Ramipril—Loss of consciousness—Doxorubicin—liver cancer	0.00103	0.00119	CcSEcCtD
Ramipril—Cough—Doxorubicin—liver cancer	0.00103	0.00118	CcSEcCtD
Ramipril—Shock—Epirubicin—liver cancer	0.00102	0.00117	CcSEcCtD
Ramipril—Convulsion—Doxorubicin—liver cancer	0.00102	0.00117	CcSEcCtD
Ramipril—Nervous system disorder—Epirubicin—liver cancer	0.00102	0.00117	CcSEcCtD
Ramipril—Thrombocytopenia—Epirubicin—liver cancer	0.00102	0.00117	CcSEcCtD
Ramipril—Tachycardia—Epirubicin—liver cancer	0.00101	0.00116	CcSEcCtD
Ramipril—Skin disorder—Epirubicin—liver cancer	0.00101	0.00116	CcSEcCtD
Ramipril—Hyperhidrosis—Epirubicin—liver cancer	0.001	0.00115	CcSEcCtD
Ramipril—Myalgia—Doxorubicin—liver cancer	0.001	0.00115	CcSEcCtD
Ramipril—Arthralgia—Doxorubicin—liver cancer	0.001	0.00115	CcSEcCtD
Ramipril—Chest pain—Doxorubicin—liver cancer	0.001	0.00115	CcSEcCtD
Ramipril—Anxiety—Doxorubicin—liver cancer	0.000999	0.00115	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000996	0.00114	CcSEcCtD
Ramipril—Discomfort—Doxorubicin—liver cancer	0.00099	0.00114	CcSEcCtD
Ramipril—Anorexia—Epirubicin—liver cancer	0.00099	0.00114	CcSEcCtD
Ramipril—Dry mouth—Doxorubicin—liver cancer	0.00098	0.00113	CcSEcCtD
Ramipril—Hypotension—Epirubicin—liver cancer	0.000971	0.00111	CcSEcCtD
Ramipril—Confusional state—Doxorubicin—liver cancer	0.000969	0.00111	CcSEcCtD
Ramipril—Oedema—Doxorubicin—liver cancer	0.000961	0.0011	CcSEcCtD
Ramipril—Anaphylactic shock—Doxorubicin—liver cancer	0.000961	0.0011	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000946	0.00109	CcSEcCtD
Ramipril—Shock—Doxorubicin—liver cancer	0.000945	0.00109	CcSEcCtD
Ramipril—Nervous system disorder—Doxorubicin—liver cancer	0.000942	0.00108	CcSEcCtD
Ramipril—Thrombocytopenia—Doxorubicin—liver cancer	0.000941	0.00108	CcSEcCtD
Ramipril—Insomnia—Epirubicin—liver cancer	0.000939	0.00108	CcSEcCtD
Ramipril—Tachycardia—Doxorubicin—liver cancer	0.000938	0.00108	CcSEcCtD
Ramipril—Skin disorder—Doxorubicin—liver cancer	0.000933	0.00107	CcSEcCtD
Ramipril—Paraesthesia—Epirubicin—liver cancer	0.000933	0.00107	CcSEcCtD
Ramipril—Hyperhidrosis—Doxorubicin—liver cancer	0.000929	0.00107	CcSEcCtD
Ramipril—Dyspnoea—Epirubicin—liver cancer	0.000926	0.00106	CcSEcCtD
Ramipril—Somnolence—Epirubicin—liver cancer	0.000923	0.00106	CcSEcCtD
Ramipril—Anorexia—Doxorubicin—liver cancer	0.000916	0.00105	CcSEcCtD
Ramipril—Dyspepsia—Epirubicin—liver cancer	0.000914	0.00105	CcSEcCtD
Ramipril—Decreased appetite—Epirubicin—liver cancer	0.000903	0.00104	CcSEcCtD
Ramipril—Hypotension—Doxorubicin—liver cancer	0.000898	0.00103	CcSEcCtD
Ramipril—Gastrointestinal disorder—Epirubicin—liver cancer	0.000897	0.00103	CcSEcCtD
Ramipril—Fatigue—Epirubicin—liver cancer	0.000895	0.00103	CcSEcCtD
Ramipril—Constipation—Epirubicin—liver cancer	0.000888	0.00102	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000876	0.00101	CcSEcCtD
Ramipril—Insomnia—Doxorubicin—liver cancer	0.000869	0.000998	CcSEcCtD
Ramipril—Paraesthesia—Doxorubicin—liver cancer	0.000863	0.000991	CcSEcCtD
Ramipril—Dyspnoea—Doxorubicin—liver cancer	0.000857	0.000984	CcSEcCtD
Ramipril—Feeling abnormal—Epirubicin—liver cancer	0.000856	0.000983	CcSEcCtD
Ramipril—Somnolence—Doxorubicin—liver cancer	0.000854	0.000981	CcSEcCtD
Ramipril—Gastrointestinal pain—Epirubicin—liver cancer	0.000849	0.000975	CcSEcCtD
Ramipril—Dyspepsia—Doxorubicin—liver cancer	0.000846	0.000971	CcSEcCtD
Ramipril—Decreased appetite—Doxorubicin—liver cancer	0.000835	0.000959	CcSEcCtD
Ramipril—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00083	0.000953	CcSEcCtD
Ramipril—Fatigue—Doxorubicin—liver cancer	0.000829	0.000951	CcSEcCtD
Ramipril—Urticaria—Epirubicin—liver cancer	0.000825	0.000948	CcSEcCtD
Ramipril—Constipation—Doxorubicin—liver cancer	0.000822	0.000944	CcSEcCtD
Ramipril—Abdominal pain—Epirubicin—liver cancer	0.000821	0.000943	CcSEcCtD
Ramipril—Body temperature increased—Epirubicin—liver cancer	0.000821	0.000943	CcSEcCtD
Ramipril—Feeling abnormal—Doxorubicin—liver cancer	0.000792	0.000909	CcSEcCtD
Ramipril—Gastrointestinal pain—Doxorubicin—liver cancer	0.000786	0.000902	CcSEcCtD
Ramipril—Hypersensitivity—Epirubicin—liver cancer	0.000765	0.000879	CcSEcCtD
Ramipril—Urticaria—Doxorubicin—liver cancer	0.000763	0.000877	CcSEcCtD
Ramipril—Abdominal pain—Doxorubicin—liver cancer	0.00076	0.000872	CcSEcCtD
Ramipril—Body temperature increased—Doxorubicin—liver cancer	0.00076	0.000872	CcSEcCtD
Ramipril—Asthenia—Epirubicin—liver cancer	0.000745	0.000856	CcSEcCtD
Ramipril—Pruritus—Epirubicin—liver cancer	0.000735	0.000844	CcSEcCtD
Ramipril—Diarrhoea—Epirubicin—liver cancer	0.000711	0.000816	CcSEcCtD
Ramipril—Hypersensitivity—Doxorubicin—liver cancer	0.000708	0.000813	CcSEcCtD
Ramipril—Asthenia—Doxorubicin—liver cancer	0.00069	0.000792	CcSEcCtD
Ramipril—Dizziness—Epirubicin—liver cancer	0.000687	0.000789	CcSEcCtD
Ramipril—Pruritus—Doxorubicin—liver cancer	0.00068	0.000781	CcSEcCtD
Ramipril—Vomiting—Epirubicin—liver cancer	0.00066	0.000758	CcSEcCtD
Ramipril—Diarrhoea—Doxorubicin—liver cancer	0.000658	0.000755	CcSEcCtD
Ramipril—Rash—Epirubicin—liver cancer	0.000655	0.000752	CcSEcCtD
Ramipril—Dermatitis—Epirubicin—liver cancer	0.000654	0.000751	CcSEcCtD
Ramipril—Headache—Epirubicin—liver cancer	0.000651	0.000747	CcSEcCtD
Ramipril—Dizziness—Doxorubicin—liver cancer	0.000636	0.00073	CcSEcCtD
Ramipril—Nausea—Epirubicin—liver cancer	0.000617	0.000708	CcSEcCtD
Ramipril—Vomiting—Doxorubicin—liver cancer	0.000611	0.000702	CcSEcCtD
Ramipril—Rash—Doxorubicin—liver cancer	0.000606	0.000696	CcSEcCtD
Ramipril—Dermatitis—Doxorubicin—liver cancer	0.000605	0.000695	CcSEcCtD
Ramipril—Headache—Doxorubicin—liver cancer	0.000602	0.000691	CcSEcCtD
Ramipril—Nausea—Doxorubicin—liver cancer	0.000571	0.000656	CcSEcCtD
